David Bumcrot

Company: CAMP4 Therapeutics
Job title: Chief Scientific Officer
Seminars:
Regulating Gene Expression by Targeting Regulatory RNAs: A Novel Therapeutic Approach 11:00 am
Highlighting regRNAs, non-coding transcripts derived from gene regulatory elements, as key regulators of transcription Targeting regRNAs with antisense oligonucleotides (ASO) leads to specific modulation of gene expression Unveiling the potential of ASOs targeting regRNAs have to be a novel class of programmable therapeutics for a range of diseasesRead more
day: Day Two